A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...

In late 2021, Amber Salzman interviewed for a job that she had no intention of taking. A relatively new start-up company, called Epicrispr Biotechnologies, was looking for a chief executive, and it ...

Core banking modernization succeeds through phased, API-driven transformation—not risky “rip-and-replace” projects—reducing ...

Soil bacteria make cocktails of molecules that synergistically inhibit the growth of microbial pathogens — suggesting a ...